
Please try another search
There’s no place to hide within the US equities risk factor spectrum, at least in absolute terms. But value stocks continue to shine on a relative basis via light losses this year. Will it last?
More importantly, can value stocks regain their mojo and at some point outperform the growth factor with higher gains for an extended period? Or is the historical value premium destined to fade into a perpetual underperforming risk premium?
By some accounts, growth and other higher-risk slices of the market will regain the lead when the current selloff ends. Maybe, but at the moment, value and related equity factors have the upper hand in 2022, based on a set of ETFs through yesterday’s close (May 9).
The top-performer year to date: Vanguard High Dividend Yield Index Fund ETF Shares (NYSE:VYM), which has shed a relatively light 3.6% so far this year. That compares with a near-16% year-to-date loss for US stocks overall (SPY) and even deeper declines in the worst-hit factors.
VYM’s trading near the bottom of its range this year, but that’s no small advantage in the current environment. Indeed, VYM’s overall profile is one of relatively stability this year.
VYM and comparable strategies are in high demand these days. “Investors want safety, they want security, and they want to go somewhere where they feel like their money is going to be a little more protected, even in a turbulent environment,” explains Ryan Jackson, an analyst of passive funds at Morningstar.
Safety in the stock market these days, however, is a relative concept. Indeed, VYM’s 3.6% year-to-date loss looks trivial compared with the near-29% tumble this year for iShares S&P 500 Growth ETF (NYSE:IVW), the hardest-hit ETF on our factor list.
Looking at VYM as a value-factor proxy relative to the broad equity market (SPY) suggests that these stocks are enjoying a renaissance after a long-simmering drought in the shadow of high-flying growth stocks.
But the advantage for value, so far, is measured only in relative terms. Losing less money is no trivial thing these days. The real test, however, still awaits, namely: Can value stocks outperform growth with higher gains?
History suggests that’s possible, even likely. Whether it holds in the months and years ahead, however, is open for debate as the crowd considers the viability of a factor strategy that’s fallen on hard times in recent years.
Shares of UnitedHealth are up around 3% since the beginning of 2022. It has grown through organic and acquisition growth Long-term investors could consider buying shares...
Before the Internet boom, FedEx (NYSE:FDX) was a barometer for the U.S. economy.At a time before DocuSign (NASDAQ:DOCU) and the like, when essential corporate documents moved via...
Below is a daily chart of the S&P 500 Index. Here are the critical aspects of the chart:The index is in a downtrend defined by a series of lower highs and lower lows. Price...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.